(Translated by https://www.hiragana.jp/)
Maggadottir, Solrun Melkork - Search Results - UAB Digital Repository of Documents
Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found
Articles 1 records found  
1.
15 p, 2.7 MB ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma / Mensali, Nadia (Department of Cellular Therapy. Oslo University Hospital) ; Köksal, Hakan (Oslo University Hospital (Oslo, Noruega)) ; Joaquina, Sandy (Oslo University Hospital (Oslo, Noruega)) ; Wernhoff, Patrick (Oslo University Hospital (Oslo, Noruega)) ; Casey, Nicholas P. (Oslo University Hospital (Oslo, Noruega)) ; Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Panisello, Carla (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rodríguez, René (Instituto de Salud Carlos III) ; Vimeux, Lene (Université de Paris) ; Juzeniene, Asta (Oslo University Hospital (Oslo, Noruega)) ; Myhre, Marit R. (Oslo University Hospital (Oslo, Noruega)) ; Fåne, Anne (Oslo University Hospital (Oslo, Noruega)) ; Castilla-Ramirez, Carolina (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Maggadottir, Solrun Melkork (Oslo University Hospital (Oslo, Noruega)) ; Duru, Adil Doganay (Nova Southeastern University) ; Georgoudaki, Anna-Maria (Department of Oncology-Pathology. Karolinska Institutet) ; Grad, Iwona (Oslo University Hospital (Oslo, Noruega)) ; Maturana, Andrés Daniel (Nagoya University) ; Gaudernack, Gustav (Oslo University Hospital (Oslo, Noruega)) ; Kvalheim, Gunnar (Department of Cellular Therapy. Oslo University Hospital) ; Carcaboso, Angel M. (Institut de Recerca Sant Joan de Déu) ; De Álava, Enrique (Universidad de Sevilla) ; Donnadieu, Emma (Université de Paris) ; Bruland, Øyvind S (University of Oslo) ; Menendez, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Inderberg, Else Marit (Oslo University Hospital (Oslo, Noruega)) ; Wälchli, Sébastien (Oslo University Hospital (Oslo, Noruega))
Osteosarcoma (OS) remains a dismal malignancy in children and young adults, with poor outcome for metastatic and recurrent disease. Immunotherapies in OS are not as promising as in some other cancer types due to intra-tumor heterogeneity and considerable off-target expression of the potentially targetable proteins. [...]
2023 - 10.1038/s41467-023-39097-x
Nature communications, Vol. 14 Núm. 1 (december 2023) , p. 3375  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.